IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 136 filers reported holding IMMUNOGEN INC in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,000 | -15.9% | 126 | 0.0% | 0.00% | – |
| Q2 2023 | $2,378 | +391.3% | 126 | 0.0% | 0.00% | – |
| Q1 2023 | $484 | -22.6% | 126 | 0.0% | 0.00% | – |
| Q4 2022 | $625 | -37.5% | 126 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 126 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 126 | -53.0% | 0.00% | – |
| Q1 2022 | $1,000 | -99.4% | 268 | -98.8% | 0.00% | -100.0% |
| Q4 2021 | $169,000 | +31.0% | 22,768 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $129,000 | -14.0% | 22,768 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $150,000 | -18.5% | 22,768 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $184,000 | +12.9% | 22,768 | -9.9% | 0.00% | 0.0% |
| Q4 2020 | $163,000 | +16200.0% | 25,268 | +9088.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 275 | +105.2% | 0.00% | – |
| Q2 2019 | $0 | – | 134 | +36.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 98 | -30.5% | 0.00% | – |
| Q3 2018 | $1,000 | – | 141 | +540.9% | 0.00% | – |
| Q1 2014 | $0 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 13,063,767 | $35,403,000 | 1.04% |
| QVT Financial LP | 1,375,900 | $3,442,000 | 0.87% |
| Virtus ETF Advisers LLC | 50,045 | $136,000 | 0.29% |
| Fernwood Investment Management, LLC | 187,000 | $507,000 | 0.27% |
| PURA VIDA INVESTMENTS, LLC | 524,600 | $1,422,000 | 0.20% |
| Endurant Capital Management LP | 184,440 | $500,000 | 0.20% |
| Birchview Capital, LP | 90,000 | $244,000 | 0.15% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 112,873 | $306,000 | 0.14% |
| DLD Asset Management, LP | 1,239,500 | $3,347,000 | 0.12% |
| DLD Asset Management, LP | 1,186,300 | $3,215,000 | 0.12% |